Pfizer Inc. (PFE) New York Stock Exchange
44.160.150.34%
CloseDecember 12, 2018

News: updated – 12-Dec 08:20


Affimed: Positive Takeaways From AFM-13 Focused R&D Day; Multiple Catalysts Ahead Including Potential Partnership With PD1/PD-L1 Company For AFM13 Combo Trial12-Dec 10:29(SeekingAlpha)

As the previous article provided a broad overview of Affimed and the opportunity for investors , this follow-up will concentrate almost exclusively on takeaways from the AFM13-focused R&D Day. Extreme market weakness on the R&D day overshadowed a positive event for Affimed ( AFMD ) …